Mandadi Tilak 4
4 · CVS HEALTH Corp · Filed Apr 4, 2023
Insider Transaction Report
Form 4
Mandadi Tilak
EVP, Chief Experience & Tech
Transactions
- Award
Stock Option
2023-04-01$74.31/sh+96,496$7,170,618→ 96,496 totalExercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (96,496 underlying)
Holdings
- 99,847
Common Stock (RSU)
Footnotes (2)
- [F1]Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 8/31/2023.
- [F2]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.